| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $66.6M | +19.7% |
| Cost of Revenue | $27.8M | +23.3% |
| Gross Profit | $38.8M | +17.2% |
| R&D Expense | $6.3M | +16.4% |
| SG&A Expense | $46.6M | +12.7% |
| Operating Income | -$14.1M | -3.2% |
| Income Tax | $51K | +325.0% |
| Net Income | -$20.0M | -32.0% |
| EPS (Basic) | -$0.93 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.2M | +46.2% |
| Accounts Receivable | $10.9M | +38.5% |
| Current Assets | $48.9M | +34.1% |
| Total Assets | $58.0M | +29.8% |
| Current Liabilities | $14.2M | +4.8% |
| Long-term Debt | $22.9M | +13.1% |
| Total Liabilities | $40.6M | +15.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.6M | -2.6% |
| Capital Expenditures | $641K | +24.5% |
| Investing Cash Flow | -$626K | -21.6% |
| Financing Cash Flow | $24.4M | +3785.5% |
| Free Cash Flow | -$14.3M | -3.4% |
| -12.0% |
| EPS (Diluted) | -$0.93 | -12.0% |
| Stockholders' Equity |
| $17.4M |
| +82.9% |